Seventure Partners — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
Animab develops proprietary antibodies that mimic natural intestinal protection mechanisms to safeguard piglets' health during post-weaning, a critical period in livestock production.
AgTechBiotechDeep TechHealthtechGhent, BE
Vikram Virdi(Chief Science Officer & Scientific Co-Founder)inAnn DepickerNico CallewaertEric CoxHenri De GreveAlain Wille(CEO)in
Co-investorsAgri Investment FundPMVQbic FundV-Bio VenturesAIFVIB
Citryll is a clinical-stage biotech developing CIT-013, an antibody therapy that targets extracellular traps by selectively binding citrullinated histones to both inhibit new trap formation and clear existing ones.
BiotechHealthtechMedical DevicesOss, NL
Renato Chirivi(Co-founder (former CSO))in
BoardPaul Peter Tak(Chair of the Board)
Co-investorsBioGeneration VenturesPureos BioventuresForbionJohnson & Johnson Innovation – JJDCBOMCurie Capital+1 more
MycoTechnology develops food and beverage ingredients using mushroom mycelial fermentation, creating flavor modulation and sugar-reduction solutions for formulators, chefs, and R&D professionals.
BiotechFoodTechNew MaterialsAurora, US
Brooks Kelly(Director)Alan Hahn(Board Member & Co-Founder)in
BoardPeter Lubar(Director)Sanjeev Krishnan(Director)Scott Horner(Director)inEphraim Lindenbaum(Director)
Co-investorsBloom8Cerity Partners VenturesCIBUS ENTERPRISE FUND II LPDAO JonesEvolution VC PartnersGaingels+14 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



















__Twitter.png)